U.S. officials request more information on MDS-Danaher transaction
MDS Inc. and Danaher Corp. have each received a second request for information from the U.S. Federal Trade Commission (FTC) regarding the sale of MDS Analytical Technologies in early September, the companies announced today.
To continue reading this article, subscribe for FREE to
Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.
